Top DOJ Atty Outlines Pharma Fraud Enforcement
The U.S. Department of Justice's Civil Division chief on Wednesday delivered a stern message to pharmaceutical industry leaders about fraud enforcement, promising expanded use of intrusive oversight agreements and continued punishment...To view the full article, register now.
Already a subscriber? Click here to view full article